Royal London Asset Management Ltd. raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.5% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 168,251 shares of the semiconductor company’s stock after buying an additional 4,092 shares during the quarter. Royal London Asset Management Ltd. owned approximately 0.11% of Synopsys worth $81,662,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Peloton Wealth Strategists lifted its position in Synopsys by 221.2% in the 3rd quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock valued at $1,459,000 after purchasing an additional 1,984 shares during the last quarter. Nordea Investment Management AB raised its holdings in shares of Synopsys by 15.9% during the fourth quarter. Nordea Investment Management AB now owns 1,043,995 shares of the semiconductor company’s stock valued at $509,261,000 after buying an additional 143,284 shares during the last quarter. James Hambro & Partners LLP boosted its position in shares of Synopsys by 30.9% during the fourth quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company’s stock worth $97,725,000 after buying an additional 47,527 shares during the period. Orion Portfolio Solutions LLC grew its holdings in Synopsys by 53.2% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 26,272 shares of the semiconductor company’s stock worth $13,304,000 after buying an additional 9,124 shares in the last quarter. Finally, Synovus Financial Corp increased its position in Synopsys by 199.2% in the 3rd quarter. Synovus Financial Corp now owns 15,062 shares of the semiconductor company’s stock valued at $7,627,000 after acquiring an additional 10,028 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Transactions at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares of the company’s stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 47,909 shares of company stock valued at $22,794,835 over the last ninety days. Corporate insiders own 0.62% of the company’s stock.
Synopsys Trading Up 0.5 %
Wall Street Analysts Forecast Growth
SNPS has been the subject of several recent analyst reports. Morgan Stanley decreased their price target on Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a research note on Monday, February 24th. Wells Fargo & Company decreased their target price on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a research report on Thursday, February 27th. Robert W. Baird dropped their price target on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Piper Sandler decreased their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $660.00 target price on shares of Synopsys in a report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $638.58.
Read Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- High Flyers: 3 Natural Gas Stocks for March 2022
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Trading Halts Explained
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Calculate Inflation Rate
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.